Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
pharmaphorum
2m
Weight loss gold rush: Developers vie for next blockbuster treatment
Weight loss treatments are rapidly becoming a focal point for pharma R&D, driven by the commercial success of Eli Lilly and ...
36m
Court tells EPA to consider fluoride risk, to dentists’ dismay
The decision could reshape a landmark public health program, but critics say the move is based on flimsy science.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Mexican mayor assassinated
Sex abuse case dismissed
Milton becomes Category 5
Human life expectancy study
Tickets to climb to $5
Richest female musician
Ranger dies during rescue
Vanderbilt, Arkansas fined
Harris on '60 Minutes'
US overdose deaths drop
Settles latest civil lawsuit
Grammy-winning singer dies
Ordered to open app store
NC voting rule changes
Targeted by a cyberattack
Win Nobel Prize in physics
North Dakota wildfires
King named grand marshal
Hamas backers sanctioned
IVF clinic's appeal rejected
TX emergency abortion case
US antitrust case advances
Hera mission launched
Liquidation plan approved
Launches asteroid probe
Athlete payments approval
Names new school board
Intel defensive briefings rise
SCOTUS denies appeal
Related topics
Ozempic
Brazil
Mylan
Wegovy
Viatris
Feedback